OptiNose, Inc.: Financial Report Reveals Stability by Mark Eisenberg 28.03.2024 OptiNose Inc. (OPTN) is a pharmaceutical company specializing in ear, nose, and throat treatments. Recent revenue was $70.99 million. Stock ...
Unlocking the Potential of Nanotubes: Membrane Technology Advancements by Lilu Anderson 22.02.2024 Researchers at KIT's Institute for Advanced Membrane Technology (IAMT) have developed nanotubes with small pores that have a highly adsorbing ...